You are viewing: UK Diabetes Care Devices Market analysis
Part of: Diabetes Care Devices Market (Global)

The UK Diabetes Care Devices Market was valued at $1017.5 Million in 2025 and projected to reach to $1727.1 Million by 2030, representing a compound annual growth rate of 11.2%. The UK diabetes care devices market is positioned for sustained growth through 2030, supported by rising diabetes prevalence and increasing healthcare investment in preventive care technologies.

UK Diabetes Care Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Diabetes Care Devices Market Trends and Insights

  • The UK market is driven by rising diabetes prevalence, increasing adoption of continuous glucose monitoring systems, and growing demand for insulin delivery devices among both Type 1 and Type 2 diabetes patients.
  • The UK's advanced healthcare infrastructure and strong NHS support for diabetes management technologies are accelerating market penetration. In the UK, innovation in connected and digital diabetes devices is reshaping the competitive landscape between 2025 and 2030.
  • The UK market benefits from favorable reimbursement policies and heightened patient awareness of self-management tools.
  • Key players are investing in UK-specific clinical trials and regulatory approvals to capture market share.
  • The UK's aging population and increasing obesity rates further support sustained demand for diabetes care devices through the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 11.2% CAGR
  • Market Size, 2025 ~USD 1017.5 Million
  • Forecast, 2030 ~USD 1727.1 Million
  • Country UK

UK Diabetes Care Devices Market Overview

Market Valuation Growth :

The UK diabetes care devices market is valued at $1,017.5 million in 2025 and is projected to reach $1,727.1 million by 2030, representing a robust 11.2% CAGR over the forecast period.

CGM System Adoption :

Continuous glucose monitoring systems are experiencing accelerated adoption across the UK, driven by NHS coverage expansion and increasing patient awareness of real-time glucose tracking benefits for improved diabetes management.

Insulin Delivery Innovation :

Advanced insulin delivery devices, including smart pens and automated insulin pumps, are gaining significant traction in the UK market as healthcare providers prioritize precision medicine and patient convenience.

Healthcare Infrastructure Advantage :

The UK's advanced healthcare infrastructure and strong NHS support for diabetes management technologies create a favorable environment for market expansion and device adoption among Type 1 and Type 2 diabetes patients.

UK Diabetes Care Devices Market Dynamics

  • NHS initiatives promoting digital health solutions and reimbursement policies favoring continuous glucose monitoring systems are key growth catalysts.
  • The market will benefit from technological advancements in insulin delivery systems and growing patient demand for connected, user-friendly devices that enable better disease management and improved quality of life. Key drivers include an aging population with higher diabetes incidence, increased adoption of remote monitoring capabilities, and growing integration of artificial intelligence in diabetes management devices.
  • UK manufacturers and healthcare providers are investing in innovation to meet evolving patient needs, while regulatory support from MHRA ensures rapid market entry for breakthrough technologies.
  • Competition among device manufacturers will intensify, driving product differentiation and pricing strategies tailored to the UK healthcare system..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The UK diabetes care devices market will grow from $1,017.5M (2025) to $1,727.1M (2030) at an 11.2% CAGR.
    • The UK market is driven by NHS support, favorable reimbursement, and rising diabetes prevalence among aging populations.
    • Continuous glucose monitoring and connected insulin delivery systems are the fastest-growing device categories in the UK.
    • The UK's digital health infrastructure and patient awareness initiatives position it as a leader in diabetes device adoption across Europe.

    Diabetes Care Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIABETES MANAGEMENT MOBILE APPLICATIONS (Product Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 12.3% from 2025 to 2030
    Largest Segment TYPE 2 DIABETES (Disease Type)
    Market Size Base Year (Billions) ~USD 34.27 (2025)
    Revenue Forecast (Billions) ~USD 61.2 (2030)
    Segments Covered Product Type, Type, Disease Type, Patient Care Settings

    UK Diabetes Care Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product Type

    • Blood Glucose Monitoring System
    • Blood Glucose Monitoring Systems
    • Diabetes Management Mobile Applications
    • Insulin Delivery Devices

    By Type

    • Continuous Glucose Monitoring Systems
    • Disposable Insulin Pens
    • Insulin Pens
    • Insulin Pumps & Accessories
    • Insulin Syringes & Needles
    • Lancets/Lancing Devices
    • Other Insulin Delivery Devices
    • Pen Needles
    • Reusable Insulin Pens
    • Self-Monitoring Blood Glucose Systems
    • Test Strips/ Test Papers
    • Test Strips/Test Papers
    • Tethered Insulin Pumps
    • Tubeless Insulin Pumps

    By Disease Type

    • Type 1 Diabetes
    • Type 2 Diabetes

    By Patient Care Settings

    • Hospitals & Diabetes Specialty Clinics
    • Self/ Home Healthcare
    • Self/Home Healthcare

    Target Audience

    • Medical Device Manufacturers : Device companies need UK-specific market data to develop localized product strategies, understand NHS procurement processes, and identify opportunities for market penetration and revenue growth in diabetes care.
    • Healthcare Providers & NHS Trusts : Hospital networks and primary care providers require market insights to optimize device procurement decisions, evaluate emerging technologies, and allocate budgets effectively for diabetes management programs.
    • Investment & Private Equity Firms : Investors targeting the UK healthcare sector need comprehensive market analysis to identify high-growth opportunities, assess company valuations, and make informed decisions on diabetes care device investments.
    • Pharmaceutical & Biotech Companies : Pharma firms developing diabetes treatments need market intelligence on complementary device ecosystems, partnership opportunities, and integrated care solutions to enhance therapeutic offerings in the UK.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts require detailed UK market data to support client advisory services, competitive benchmarking, and strategic recommendations in the diabetes care devices sector.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise UK market valuation ($1,017.5M in 2025) and 5-year forecast data to validate investment decisions and competitive positioning in the rapidly expanding diabetes care devices sector.
    • UK-Specific Regulatory Insights : Understand MHRA approval pathways, NHS reimbursement criteria, and UK-specific compliance requirements essential for product launches and market entry strategies in the British healthcare system.
    • Competitive Landscape Analysis : Identify leading UK and international device manufacturers, their market share, product portfolios, and differentiation strategies to benchmark performance and identify partnership or acquisition opportunities.
    • Patient Adoption Trends : Access detailed insights on UK patient preferences for CGM systems, insulin pumps, and connected devices, including adoption barriers and drivers specific to Type 1 and Type 2 diabetes populations.
    • Strategic Growth Opportunities : Discover emerging segments, underserved patient demographics, and technology gaps in the UK market to inform product development, market expansion, and revenue diversification strategies.

    Frequently asked questions

    What is the current size of the UK diabetes care devices market?

    The UK diabetes care devices market is valued at $1,017.5 million in 2025 and is projected to reach $1,727.1 million by 2030.

    What is the growth rate of the UK diabetes care devices market?

    The UK diabetes care devices market is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2030.

    Which devices are driving growth in the UK market?

    Continuous glucose monitoring systems, insulin pumps, and connected digital diabetes management devices are the primary growth drivers in the UK market.

    How does NHS reimbursement impact the UK diabetes care devices market?

    NHS reimbursement policies and coverage for diabetes devices significantly accelerate adoption rates and market expansion across the UK.

    What factors support long-term growth in the UK market through 2030?

    Rising diabetes prevalence, an aging population, obesity trends, digital health infrastructure, and patient awareness initiatives support sustained growth in the UK market.

    RESEARCH METHODOLOGY

    The study involved four main activities to estimate the current size of the diabetes care devices market. First, extensive secondary research was conducted to gather information about the market, including related and parent markets. The next step was validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Both top-down and bottom-up methods were used to develop a comprehensive estimate of the overall market size. Lastly, market segmentation and data triangulation techniques were employed to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the diabetes care devices market. It also helped obtain critical insights about key industry players, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, we conducted interviews with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the diabetes care devices market, were interviewed. For the demand side, engagement with industry experts, purchase and sales managers, doctors, and personnel from research organizations was done. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the diabetes care devices market is provided below:

    Diabetes Care Devices Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the diabetes care devices market includes the following details.

    The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the diabetes care devices market was determined from annual presentations by leading companies and publicly available secondary data. The share of products and services within the overall diabetes care devices market was calculated using secondary data and verified by primary participants to arrive at the total market size. Primary participants also further validated the data numbers.

    Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each stage, the assumptions and approaches were verified with industry experts contacted during primary research. Due to limitations in the data from secondary research, revenue estimates for individual companies (covering the overall diabetes care devices market and geographic market assessment) were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.

    Global Diabetes Care Devices Market Size: Bottom-up and Top-down Approach

    Diabetes Care Devices Market

    Data Triangulation

    After determining the overall size from the market size estimation process described above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures outlined below were applied, where appropriate, to complete the overall market analysis and obtain precise statistics for various segments. The data was triangulated by examining different factors and trends from both demand and supply perspectives. Additionally, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    The diabetes care devices includes medical technologies and tools used for monitoring, managing, and treating diabetes. It features blood glucose monitoring systems (such as glucometers, continuous glucose monitors, test strips, and lancets), insulin delivery devices (including insulin pens, pumps, syringes, and automated delivery systems), and related accessories. These devices help track glucose accurately, deliver insulin effectively, and improve patient outcomes by enabling better disease control, reducing complications, and enhancing quality of life. The market serves patients, healthcare providers, and caregivers and is driven by technological innovations, the rising prevalence of diabetes, and increasing demand for connected, user-friendly solutions.

    Stakeholders

    • Diabetes Care Devices’ Manufacturing Companies
    • Contract Manufacturers
    • Distributors, Suppliers, and Channel Partners of Diabetes Care Devices
    • Senior Management
    • Finance Department
    • Procurement Department
    • Hospitals & Clinics
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Academic & Research Institutes
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyse, and forecast the global diabetes care devices  market by product type, disease type, patient care settings, and region
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the diabetes care devices  market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries
    • To profile the key players in the diabetes care devices  market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the diabetes care devices  market

     

    Get the Full Diabetes Care Devices Market Report

    Full forecast, segment splits, and company analysis for all Diabetes Care Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status